W. Va. Code R. § 64-110-11

Current through Register Vol. XLI, No. 50, December 13, 2024

Section 64-110-11 - Limit on medical cannabis processing

11.1. In the form intended to be sold to another medical cannabis organization, medical cannabis must have a specific concentration of total THC and total CBD and must have a consistent cannabinoid profile. The concentration of the following cannabinoids, at a minimum, must be reported to the bureau by an approved laboratory and include the following on the label:

11.1.a. Tetrahydrocannabinol (THC);

11.1.b. Tetrahydrocannabinol acid (THCA);

11.1.c. Tetrahydrocannabivarin (THCV);

11.1.d. Cannabidiol (CBD);

11.1.e. Cannabinadiolic acid (CBDA);

11.1.f. Cannabidivarine (CBDV);

11.1.g. Cannabinol (CBN);

11.1.h. Cannabigerol (CBG);

11.1.i. Cannabichromene (CBC); and

11.1.j. Any other cannabinoid component at 0.1 percent.

11.2. Within the first six months after the bureau determines the grower/processor to be operational, the grower/processor must provide the bureau with a forecast of the amount of medical cannabis it projects it will produce and in what form. The grower/processor must notify the bureau in writing immediately upon becoming aware of a potential increase or decrease in the forecasted amount occurring within any subsequent six-month period.

W. Va. Code R. § 64-110-11